MSN Labs unveils generic Favipiravir under brand name Favilow 800 mg at Rs 144 per tablet Ruchika Sharma29 April 2021 12:00 PM ISTNew Delhi: MSN Laboratories on Wednesday said it has launched the generic version of antiviral drug Favipiravir in 800 mg strength for treating...
Macleods Pharma gets CDSCO panel okay for BE study of COVID drug Favipiravir Powder for Oral Suspension Medical Dialogues Team16 April 2021 4:48 PM ISTNew Delhi: Pharmaceutical major Macleods Pharma has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Fujifilm to restart clinical trial of Avigan for COVID-19 treatment: Report Ruchika Sharma22 Feb 2021 12:30 PM ISTTokyo: Fujifilm Holdings Corp will restart a clinical trial in Japan of its antiviral drug Avigan for the treatment of COVID-19, the Nikkei newspaper...
Favipiravir use in COVID-19 patients may lead to nephrotoxicity: Case study MD Bureau11 Jan 2021 7:14 PM ISTSince December 2019, a novel coronavirus called SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has caused an international outbreak of...
Dr Reddys, Global Response Aid, Appili Therapeutics file for COVID drug REEQONUS Ruchika Sharma23 Dec 2020 1:36 PM ISTREEQONUS is also known as Avigan (favipiravir) Tablets developed by FUJIFILM Toyama Chemical Co., Ltd.
Favipiravir shows significant improvement in COVID clinical cure: Glenmark Ruchika Sharma24 Nov 2020 1:00 PM ISTFavipiravir is an antiviral medication that works by inhibiting a viral enzyme called RdRP (RNA dependent RNA polymerase), thereby halting the virus's...
Hyderabad-based startup Aptus Therapeutics develops novel Favipiravir production method MD Bureau21 Nov 2020 1:30 PM ISTThe start-up says that the developed synthetic process technology is cost-effective and eco-friendly as it uses less solvents and easy to isolate the...
Macleods Pharma proposes chewable Faviparavir, gets rejected by CDSCO panel Farhat Nasim12 Nov 2020 4:57 PM ISTNew Delhi: In a major setback to Mumbai-based drugmaker Macleods Pharmaceuticals Ltd, the Subject Expert Committee (SEC) functional under the Central...
Drug firm FDC launches stronger versions of Favipiravir at Rs 160 per tablet in India Ruchika Sharma31 Oct 2020 1:00 PM ISTThe 800 mg version of the drugs will help reduce the number of tablets to be taken by any patient by 75 percent, it added.
Use of Remdesivir, Favipiravir drugs to treat COVID- 19: SC Asks Centre to clarify stand Ruchika Sharma30 Oct 2020 12:00 PM ISTRemdesivir and Favipiravir are antiviral drugs and their efficacy in treating Covid-19 patients has been a matter of debate among medical experts.
Test efficacy of umifenovir alone, not with favipiravir for COVID cure: CDSCO panel to Macleods Pharma Farhat Nasim17 Oct 2020 2:00 PM ISTNew Delhi: Mumbai-based Macleods Pharma recently asked permission to test the influenza drug, Umifenovir Hydrochloride along with Favipiravir, as a...
Death During Glenmark Favipiravir-Umifenovir Trial: CDSCO seeks adverse event report Farhat Nasim15 Oct 2020 12:34 PM ISTNew Delhi: The Mumbai-based drugmaker, Glenmark Pharmaceuticals Ltd., has been directed by the apex drug regulator, Central Drugs Standard Control...
